Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)

Part of paid clinical trials in Cincinnati, Ohio.

Sponsor
David M. Ritter
Study ID
NCT06160310
Status
Recruiting
Apply to this trial

Conditions

  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis Complex

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This study is an observational registry designed to gather information about Tuberous Sclerosis Complex (TSC) and Lymphangioleiomyomatosis (LAM) in pregnant women and their child.

Key Dates

Start date
Jul 1, 2023
Status verified
Jan 2026
Primary completion
Jul 1, 2028
Completion
Jul 1, 2029

Study Design

Enrollment
300 participants (estimated)

Primary Outcome Measure

Safety of mTOR inhibitor in Pregnancy -- mTOR inhibitor adherence [ Time Frame: During pregnancy (up to 40 weeks) through 6 months post-delivery ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cincinnati Children's Hospital Medical CenterCincinnatiOhio45229
Molly S Griffith, BA
[email protected]
513-636-9669
Adrienne Victory
[email protected]
513-636-8016
David M Ritter, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Cincinnati, OH

By research site
Cincinnati Children's Hospital Medical Center· Cincinnati, OH

Related Studies